Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q2 2022 call → NOWe need to determine if management's forward account is based on narrating what its counterparties are themselves doing and scaling. The question asks: does management explain where the company's business is going by narrating what its counterparties are themselves doing and scaling? That is, does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company already supplies or serves, such that the company's own coming volume is presented as a consequence of those parties' own trajectories rather than of the company's selling effort? We need to look at the transcript. Management (Yogesh and Anthony) discuss the company's performance, guidance, M&A, price increases, etc. They talk about the business being predictable, mission-critical, etc. They mention that they are not seeing changes in customer behavior. They talk about price increases and how they are implementing them. They talk about M&A environment. They do not specifically narrate the growth or scaling of specific counterparties. They mention that they have over 1,700 ISVs who embed their products, and as those ISVs raise prices, they indirectly benefit. But that is not a narrative of those ISVs' own trajectories. They don't describe specific customers' ramps, launches, or expansions. They talk about the overall demand environment being steady. They mention that they are not seeing any change in customer behavior. They don't provide a forward account that is based on reporting on somebody else's expansion. The forward account is based on their own execution, M&A, price increases, and the stability of their business. They do mention that they are seeing early signs of a shift towards a more bio-friendly environment for M&A, but that's about the market, not about specific counterparties' growth. Thus, the answer is NO. The management does not narrate what its counterparties are themselves doing and scaling. They talk about their own actions and broad market conditions. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.